Site-directed fragment-based generation of virtual sialic acid databases against influenza A hemagglutinin
- 145 Downloads
In this study fragment-based drug design is combined with molecular docking simulation technique, to design databases of virtual sialic acid (SA) analogues with new substitutions at C2, C5 and C6 positions of SA scaffold. Using spaces occupied by C2, C5 and C6 natural moieties of SA when bound to hemagglutinin (HA) crystallographic structure, new fragments that are commercially available were docked independently in all the pockets. The oriented fragments were then connected to the SA scaffold with or without incorporation of linker molecules. The completed analogues were docked to the whole SA binding site to estimate their binding conformations and affinities, generating three databases of HA-bound SA analogues. Selected new analogues showed higher estimated affinities than the natural SA when tested against H3N2, H5N1 and H1N1 subtypes of influenza A. An improvement in the binding energies indicates that fragment-based drug design when combined with molecular docking simulation is capable to produce virtual analogues that can become lead compound candidates for anti-flu drug discovery program.
KeywordsFragment-based molecular design Hemagglutinin Influenza A Molecular docking Sialic acid analogues
We would like to acknowledge Mr. Andreas Meyer from ChemBridge Corporation. Mr Al-Qattan appreciates Universiti Sains Malaysia for supporting this project through a research fellowship scheme.
- 2.Schauer R, Kamerling JP (1997) Chemistry, biochemistry and biology of sialic acids. In: Montreuil J, Vliegenthart JFG, Schachter H (eds) New comprehensive biochemistry, vol 29b. Elsevier Science BV, Amsterdam, The Netherlands, pp 243–402Google Scholar
- 6.Ward CW, Dopheide TA (1981) Amino acid sequence and oligosaccharide distribution of the haemagglutinin from an early Hong Kong influenza virus variant A/Aichi/2/68 (X-3 1). Biochem J 193:953–962Google Scholar
- 8.Von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, Phan TV, Smythe ML, White HF, Oliver SW, Colman PM, Varghese JN, Ryan DM, Woods JM, Bethell RC, Hotham VJ, Cameron JM, Penn CR (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363:418–423CrossRefGoogle Scholar
- 10.Sauter NK, Hanson JE, Glick GD, Brown JH, Crowther RL, Park SJ, Skehel JJ, Wiley DC (1992) Binding of influenza virus hemagglutinin to analogs of its cells urface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry 31:9609–9621CrossRefGoogle Scholar
- 12.Pritchett TJ (1987) Receptor analogue inhibitors of influenza virus adsorption and infection. (thesis), Univ of California, Los AngelesGoogle Scholar
- 15.Sauter NK, Bednarski MD, Wurzburg BA, Hanson JE, Whitesides GM, Skehel JJ, Wiley DC (1989) Hemagglutinins from two influenza virus variants bind to sialic acid derivatives with millimolar dissociation constants: a 500 MHz proton nuclear magnetic resonance study. Biochemistry 28:8388–8396CrossRefGoogle Scholar
- 17.Hurt AC, Ernest J, Deng Y-M, Iannello P, Besselaar TG, Birch C, Buchy P, Chittaganpitch M, Chiu S-C, Dwyer D, Guigon A, Harrower B, Kei IP, Kok T, Lin C, McPhie K, Mohd A, Olveda R, Panayotou T, Rawlinson W et al (2009) Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antivir Res 83:90–93CrossRefGoogle Scholar
- 18.Mohammed Noor Al-qattan, Mohd Nizam Mordi, Docking of sialic acid analogues against influenza A hemagglutinin : A correlational study between experimentally measured and computationally estimated affinities. (Accepted for Publication, J Mol Mod)Google Scholar
- 26.Höltje H-D, Sippl W, Rognan D, Folkers G (1997) Molecular modeling: basic principles and applications, 3rd edn. VCH Verlagsgesellschaft GmbH, Weinheim, Germany, pp 192Google Scholar